2025-12-19 - Analysis Report
Here's a comprehensive analysis of Hims & Hers Health Inc. (HIMS) based on the provided data:

**0) Overview**

This report provides an analysis of Hims & Hers Health Inc. (HIMS) stock, comparing its performance to the S&P 500 (VOO) and examining various financial indicators and recent news.

**1) Return Rate Comparison**

*   **Company Overview:** Hims & Hers Health Inc. is a telehealth company offering personalized health and wellness solutions.
*   **HIMS Cumulative Return:** 124.48%
*   **VOO (S&P 500) Cumulative Return:** 73.05%
*   **Divergence:**
    *   Current: 68.3
    *   Relative Divergence: 37.9

**Analysis:** HIMS has significantly outperformed the S&P 500 over the analyzed period. The divergence of 68.3 indicates a substantial difference in cumulative returns. The relative divergence of 37.9 suggests the current divergence is in the lower half of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha    | Beta    | Cap(B) |
|------------|----------|-------|----------|---------|--------|
| 2019-2021  | -42.0%   | 74.4% | -81.0%   | 0.0     | 1.5    |
| 2020-2022  | -19.0%   | 78.6% | -18.0%   | -0.0    | 1.5    |
| 2021-2023  | -65.0%   | 78.6% | -67.0%   | -0.1    | 2.0    |
| 2022-2024  | 119.0%   | 79.4% | 98.0%    | -0.0    | 5.5    |
| 2023-2025  | 129.0%   | 80.8% | 65.0%    | 0.1     | 7.9    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows volatile performance, with significant negative returns in earlier periods and substantial growth more recently.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant price volatility and risk.
*   **Alpha:** Alpha measures the stock's performance relative to the market. Negative alpha values in the earlier periods suggest underperformance, while the positive values in more recent periods indicate outperformance.
*   **Beta:** Beta measures the stock's volatility relative to the market. Beta values close to zero suggest that the stock's price is not highly correlated with the market.
*   **Cap(B):** Market capitalization has significantly increased, indicating growing investor confidence and company value.

**2) Recent Stock Price Fluctuations**

*   **Close Price:** 34.77
*   **Last Market Data:** Price: 34.77, Previous Close: 34.97, Change: -0.57
*   **5-day SMA:** 36.012
*   **20-day SMA:** 37.258
*   **60-day SMA:** 44.8839

**Analysis:** The stock price is currently below all three Simple Moving Averages (SMAs), suggesting a potential downtrend. The 5-day SMA is below the 20-day SMA, which is below the 60-day SMA, further supporting this observation.

**3) Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 32.66 (Approaching Oversold)
*   **PPO:** 0.0261
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (27 shares - Very Safe - MRI:0.90)
*   **Recent Relative Divergence Change:** 1.1 (+) (Short-term increase)
*   **Expected Return:** 24.2% (Long-term)

**Analysis:**

*   The MRI of 0.7 indicates a medium level of investment risk.
*   The RSI of 32.66 suggests the stock is nearing oversold conditions, potentially signaling a buying opportunity.
*   The PPO indicates the stock price is above its moving average (positive indicator).
*   The Hybrid Signal recommends a strong buy, based on its algorithm.
*   The recent increase in relative divergence suggests a short-term upward trend.
*   The expected return of 24.2% is significantly higher than the S&P 500, suggesting potential for long-term gains.

**4) Recent News & Significant Events**

*   **Positive News:**
    *   Focus on Expansion and Technology-Driven Care
    *   Share Repurchase Program Authorization
    *   Positive assessments after partnerships and year-to-date price surge.
*   **Negative News:**
    *   Analyst Selling Shares
    *   Why Is Hims & Hers Stock Falling
    *   Volatility in the stock price.

**Analysis:** Recent news presents a mixed picture. While expansion plans and share repurchase programs are positive, analyst selling shares and discussion of a price fall introduce caution.

**4-2) Analyst Opinions**

*   **Consensus:** Hold
*   **Mean Rating:** 2.93 (Hold)
*   **Number of Opinions:** 12
*   **Target Price:**
    *   Average: 44.67
    *   High: 85.00
    *   Low: 25.00
*   **Recent Rating Changes:** Not Specified (but indicated as no changes)

**Analysis:** Analyst consensus is a "Hold" rating, suggesting a neutral outlook on the stock. The average target price of $44.67 implies potential upside from the current price. The wide range between the high and low target prices indicates varying levels of confidence among analysts.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-11-03 | 0.07 | 0.60 B$    |
| 2025-08-04 | 0.19 | 0.54 B$    |
| 2025-05-05 | 0.22 | 0.59 B$    |
| 2024-11-04 | 0.35 | 0.40 B$    |
| 2025-11-03 | 0.35 | 0.40 B$    |

**Analysis:** Revenue shows a clear upward trend over the recent quarters.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-09-30 | $0.60B   | 73.80%        |
| 2025-06-30 | $0.54B   | 76.39%        |
| 2025-03-31 | $0.59B   | 73.50%        |
| 2024-12-31 | $0.48B   | 76.81%        |
| 2024-09-30 | $0.40B   | 79.16%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-09-30 | $0.58B   | 2.72%   |
| 2025-06-30 | $0.56B   | 7.55%   |
| 2025-03-31 | $0.55B   | 9.01%   |
| 2024-12-31 | $0.48B   | 5.46%   |
| 2024-09-30 | $0.44B   | 17.18%  |

**Analysis:** Revenue has consistently increased, while profit margins have remained relatively stable. Equity has also grown, but ROE has decreased significantly, indicating potentially less efficient use of equity.

**7) Comprehensive Analysis**

**Summary:**

Hims & Hers Health Inc. (HIMS) exhibits strong recent growth in revenue and a high potential for future gains (24.2% expected return). It has significantly outperformed the S&P 500. However, the stock exhibits high volatility (as evidenced by the MDD and Beta). Analyst sentiment is neutral.

**Recommendation:**

The stock appears to be currently in a short-term downtrend but nearing oversold conditions. Investors should consider the mixed news flow (positive expansion versus analyst selling and falling stock price). While the company has a high-growth potential, the current indicators and expert consensus suggest being cautious and maintaining a well-diversified portfolio.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.